Participate in research

Below are ongoing clinical and observational trials, open to participation. Please click on the picture for more information.

Klinisch Onderzoek Naar Depressie

  Nieuw geneesmiddelen onderzoek naar behandelingsresistente depressie: patienten die een psychedelisch onderzoeksmedicijn willen proberen om een depressieve stoornis te behandelen kunnen nu worden toegelaten Een fase 1/2 onderzoek bij patiënten met een behandelingsresistente depressie Algemene informatie: Dit onderzoek wordt uitgevoerd door de Faculteit Psychologie en Neurowetenschappen van de Universiteit Maastricht (Universiteitssingel 40, Maastricht). Een commerciële… Continue reading Klinisch Onderzoek Naar Depressie

Microdosing with Mescaline

“Microdosing with Mescaline” Neuropsychology and Psychopharmacology; Maastricht University ERCPN code: 215_06_11_2019 The University of Maastricht has started a study regarding the effects of mescaline (found in cacti like San Pedro) microdosing on mental wellbeing and memory. For this study we seek males and females who intend to start microdosing with mescaline on their own initiative.… Continue reading Microdosing with Mescaline

Have you ever taken a novel psychedelic substance?

Have you ever taken a novel psychedelic substance? Please consider taking part in our new survey! What’s the survey about? We are about to start a range of experimental trials with novel psychoactive drugs, but we are missing important information- these include things like dose, and experienced positive and negative effects. So, as the scientific… Continue reading Have you ever taken a novel psychedelic substance?

3 Minutes of Mindfulness

“3 minutes of Mindfulness” Neuropsychology and Psychopharmacology; Maastricht University ERCPN code: 222_76_04_2020   The University of Maastricht has started a study regarding the effects of Mindfulness on mental wellbeing and memory. For this study we seek males and females who intend to start Mindfulness practice on own initiative.   The study is conducted online. Before… Continue reading 3 Minutes of Mindfulness

CLINICAL STUDY FOR TREATMENT-RESISTANT DEPRESSION – A new psychedelic drug is being investigated for treatment of depression in Maastricht. Patients can now be enrolled.

  A phase 1/2 study in patients with treatment-resistant depression General information: This study is being carried out by the Faculty of Psychology and Neuroscience of Maastricht University (Universiteitssingel 40, Maastricht). A commercial sponsor is paying for the costs of this study. The Medical Ethics Committee of the University Hospital Maastricht and Maastricht University (METC… Continue reading CLINICAL STUDY FOR TREATMENT-RESISTANT DEPRESSION – A new psychedelic drug is being investigated for treatment of depression in Maastricht. Patients can now be enrolled.